Specificity of the immunosuppressive action of carbimazole in Graves's disease.
作者信息
McGregor A M, Rees Smith B, Hall R, Collins P N, Franco Bottazzo G, Petersen M M
出版信息
Br Med J (Clin Res Ed). 1982 Jun 12;284(6331):1750-1. doi: 10.1136/bmj.284.6331.1750.
Abstract
摘要
相似文献
1
Specificity of the immunosuppressive action of carbimazole in Graves's disease.卡比马唑在格雷夫斯病中免疫抑制作用的特异性。
Br Med J (Clin Res Ed). 1982 Jun 12;284(6331):1750-1. doi: 10.1136/bmj.284.6331.1750.
2
Specificity of the immunosuppressive action of carbimazole in Graves's disease.卡比马唑在格雷夫斯病中免疫抑制作用的特异性。
Br Med J (Clin Res Ed). 1982 Jul 10;285(6335):137. doi: 10.1136/bmj.285.6335.137-a.
3
Carbimazole and the autoimmune response in Graves' disease.卡比马唑与格雷夫斯病中的自身免疫反应。
N Engl J Med. 1980 Aug 7;303(6):302-7. doi: 10.1056/NEJM198008073030603.
4
Prediction of relapse in hyperthyroid Graves' disease.甲状腺功能亢进型格雷夫斯病复发的预测
Lancet. 1980 May 24;1(8178):1101-3. doi: 10.1016/s0140-6736(80)91551-2.
5
[Prognostic value of anti-TSH receptor antibodies in Basedow's disease treated with carbimazole].[抗促甲状腺激素受体抗体在接受甲巯咪唑治疗的弥漫性毒性甲状腺肿中的预后价值]
Ann Med Interne (Paris). 1986;137(7):555-8.
6
T lymphocyte subsets at various stages of hyperthyroid Graves' disease: effect of carbimazole treatment and relationship with thyroid-stimulating antibody levels or HLA status.甲状腺功能亢进型格雷夫斯病不同阶段的T淋巴细胞亚群：卡比马唑治疗的效果及其与促甲状腺素受体抗体水平或人类白细胞抗原状态的关系
J Clin Endocrinol Metab. 1986 Jan;62(1):117-21. doi: 10.1210/jcem-62-1-117.
7
Time and tides in Graves's disease: their implications in predicting outcome of treatment.格雷夫斯病中的时间与趋势：它们在预测治疗结果中的意义
Br Med J. 1979 Jan 13;1(6156):88-9. doi: 10.1136/bmj.1.6156.88.
8
Changes in thyroid-stimulating antibody activity in Graves' disease treated with antithyroid drug and its relationship to relapse: a prospective study.抗甲状腺药物治疗Graves病时促甲状腺素抗体活性的变化及其与复发的关系：一项前瞻性研究。
J Clin Endocrinol Metab. 1980 Jan;50(1):144-7. doi: 10.1210/jcem-50-1-144.
9
Thyrotoxicosis: relations between clinical state and biochemical changes during carbimazole treatment.甲状腺毒症：卡比马唑治疗期间临床状态与生化变化的关系。
Br Med J. 1977 Jan 15;1(6054):138-41. doi: 10.1136/bmj.1.6054.138.
10
Triiodothyronine antibodies in a case of Graves' disease: long-term follow-up under carbimazole.
Horm Metab Res. 1991 Mar;23(3):148. doi: 10.1055/s-2007-1003638.
引用本文的文献
1
Are antithyroid drugs immunosuppressive?抗甲状腺药物具有免疫抑制作用吗？
Br Med J (Clin Res Ed). 1984 Feb 18;288(6416):509-11. doi: 10.1136/bmj.288.6416.509.
2
3
Graves' disease and Hashimoto's thyroiditis: effects of high doses of antithyroid drugs on thyroid autoantibody levels.格雷夫斯病和桥本甲状腺炎：高剂量抗甲状腺药物对甲状腺自身抗体水平的影响。
J Endocrinol Invest. 1986 Jun;9(3):233-8. doi: 10.1007/BF03348107.
本文引用的文献
1
Carbimazole and the autoimmune response in Graves' disease.卡比马唑与格雷夫斯病中的自身免疫反应。
N Engl J Med. 1980 Aug 7;303(6):302-7. doi: 10.1056/NEJM198008073030603.
2
Thyroid-autoantibody synthesis by Hashimoto thyroid lymphocytes.
Lancet. 1979 Jan 20;1(8108):162-3. doi: 10.1016/s0140-6736(79)90559-2.
3
Antithyroid drugs.抗甲状腺药物
Pharmacol Ther B. 1978;3(3):305-48. doi: 10.1016/s0306-039x(78)80001-4.
4
35-S-antithyroid drug concentration and organic binding of iodine in the human thyroid.人体甲状腺中35-S-抗甲状腺药物浓度及碘的有机结合
Clin Endocrinol (Oxf). 1975 Nov;4(6):609-15. doi: 10.1111/j.1365-2265.1975.tb01930.x.
Zotero 插件